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Toxin-mediated diseases have made human
beings ill for millennia and many of them had
catastrophicall character. The use of biological agents
as weapons of terror has been realised, and separating
naturally occurring disease from bioterroristic events
has become an important public health goal. The
key to timely identification of such attacks relies
on education of primary care physicians, first responders,
and public health officials.
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ABSTRACT
Biotoxins are toxic substances produced by a living organism that cause diseases in human
beings, animals, or plants. The agent may be lethal or incapacitating. The new, emerging threat
agents are biotoxins produced by animals, plants, fungi, and bacteria. Many types of organisms
produce substances that are toxic to humans. Examples of such biotoxins are botulinum toxin,
tetanus toxin, and ricin. Several bioactive molecules produced by the pharmaceutical industry
can be even more toxic than the classical chemical warfare agents. Such new agents, like the
biotoxins and bioregulators, often are called mid-spectrum agents. The threat to human beings
from agents developed by modern chemical synthesis and by genetic engineering also must be
considered, since such agents may be more toxic or more effective in causing death or
incapacitation than classical warfare agents. By developing effective medical protection and
treatment against the most likely chemical and mid-spectrum threat agents, the effects of such
agents in a war scenario or following a terrorist attack can be reduced. Toxin-mediated diseases
have made human beings ill for millennia. The use of biological agents as weapons of terror has
now been realised, and separating naturally occurring disease from bioterroristic events has
become an important public health goal.
 Keywords: Biotoxin, bioterrorism,  toxic protei, ricin, abrin, viscumin, volkenesin, modeccin,
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Staphylococcus toxin, shiga toxin, verotoxin, cholera toxin, tetanus toxin, microcystin,
mid-spectrum agents
Natural toxins are toxic compounds produced
by living organism1,2. There are principle toxic
substances of poisonous animals, plants, microorganisms
and other forms of life. Such agents, like the biotoxins,
often are called mid-spectrum agents3. The manner
of their toxic effect can be different in individual
substances. According to the organ toxicity, the
neurotoxins, hepatotoxins, nephrotoxins, hemotoxins,
etc. can be distingished. For example neurotoxins
are toxic agents or substances that damage or
destroy the tissues of the nervous system, especially
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neurons. Neurotoxic effects can include behaviour
changes, seizures, as well as wide range of effects,
including death. According to the chemical structure,
it is possible to divide all natural toxins (biotoxins) into
nonprotein and protein compounds. This review covers
peptide toxins which are on the control list of chemical
weapons. Each toxin is briefly characterised chemically,
pharmacologically, and toxicologically. Their natural
sources, availability, stability, and military potential
are discussed.
2 . BIOTOXINS AND CHEMICAL WEAPONS
CONVENTION
Biotoxins are used in nature for two primary
reasons: (i) predation (spider, snake, jellyfish, wasp)
and (ii) defence (honeybee, poison dart frog, deadly
nightshade). All of these are very toxic compounds
and many of them represent a risk for human
health and the viability of organisms. That is why
biotoxins can be employed in warfare and in terrorist
attacks4. Chemical Weapons Convention (CWC)
(1993) includes toxins as chemical agents, and
specifically includes toxins in its control regime
along with other highly toxic chemicals. Protein
toxins are: Abrin, botulinum, Clostridium perfringens,
Corynebacterium diphteriae, microcystins,
Staphylococcus aureus, ricin, shigatoxin, and tetanus.
On the control list of the Australian Group, a voluntary
asssociation of 33 countries, are also conotoxins,
verotoxin, cholera toxin, modeccin, volkensin and
viscumin are enregistered.
Botulinum toxin produces a descending flaccid
paralysis5. Staphylococcal enterotoxin B produces
a syndrome of fever, nausea, and diarrhea and may
produce a pulmonary syndrome if aerosolised.
Clostridium perfringens epsilon-toxin could possibly
be aerosolised to produce acute pulmonary edema.
Ricin intoxication can manifest as gastrointestinal
hemorrhage after ingestion, severe muscle necrosis
after intramuscular injection, and acute pulmonary
disease after inhalation6. All these biotoxins may
be perilous if they will be misused by terrorists7.
3 . PROTEIN BIOTOXIN CLASSIFICATION
All peptide toxins are created by one of more
linear or cyclic polypeptide chains. Polypeptide is
constructed from more amino acids connected by
means of peptide linkage.
Proteins are large macromolecules composed
of one or more peptide chain. It is possible to say
that polypeptides composed from less number of
amino acids are designated as peptides or polypeptides,
from the larger number as proteins. The crossover
between peptides and proteins is not defined exactly
and is unsubstantial from practice point of view.
The biological mechanism of biotoxin action as
well as development of their toxic manifestation,
clinical course, and therapy pretensions are very
different.
3.1 PLANT TOXINS
Plant toxic proteins belong to a group of phytotoxins,
which inhibit the protein synthesis of eukaryotic
cells. The toxins of this group are glycoproteins
with molecular weights of about 60 kDa which
consist of two subunits linked into a dimer by a
disulphide bond. One of the subunits is lectin with
sites for carbohydrate binding (B-chain), and the
other subunit is specific N-glycosidase (A-chain),
which modifies the 28S rRNA-60S ribosomal subunit8.
The group of proteins known as the lectins
was first recognised in plant seeds and they bind
to specific sugars. Although lectins, in general, are
not very toxic, there are some relationships between
lectins and toxins9. They may also serve as recognition
markers in cellular differentiation and act as
immunotoxin. Only A-chain is toxic due to inhibiting
protein synthesis. The A-chain catalytically inactivates
60S ribosomal subunit by removing adenine from
positions 4 and 324 of 28S rRNA. Ribosome-inactivating
proteins (RIP) have been identified in many plants
and some of them are very toxic, but only in connection
with B-chain10. The A-chain is carrier of toxicity,
but B-chain binds to cell surface receptors and
facilitates a transport of the A-chain across the
cell membrane. The A-chain is not active until it
internalised by the cell, where halts protein synthesis11.
Each toxin molecule can disable approximately
2000 polysomes per minute, enough to eventually
kill the cell. The most known plant toxic proteins
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of this type are ricin, abrin, modessin, viscumin
and volkensin12,13.
3.1.1 Ricin
Ricin is a protein produced by the castor oil
plant, Ricinus communis. It is native to tropical
Africa, but has naturalised sub-tropical and temperate
areas as well. The whole of the plant is poisonous,
containing the toxin ricin, which reaches the highest
levels in the seeds. The seeds also contain a purgative
oil, the triglyceride of ricinoleic acid. The seeds
have been used in folk medicine against many
diseases (eg. remedies for abscess, anasarca, arthritis,
asthma, boils, burns, cancer) for centuries.
Ricin is the only toxin to exist naturally in
large quantities. It is a byproduct of castor oil
production and ricin isolation and seperation is
simple and cheap. Easy preparation and low price
might make this toxin attractive to a poor country.
For nations or terrorists who lack the money to
spend on nuclear weapons and other high-tech
killing instruments, toxin warfare offers horrific
appeal as biological/toxin weapons are cheap, easy
to make, and simple to conceal. Even small amounts,
if effectively used, could cause massive injuries
and make many suffers14. Ricin's significance as
a potential biological warfare toxin relates in part
to its wide availability. Worldwide, one million ton
of castor beans are processed annually to produce
castor oil and in the waste there is five per cent
ricin by weight. The toxin is also quite stable and
extremely toxic by several routes of exposure,
including the respiratory route15.
Ricin is the compound responsible for toxicity
of the seeds of Ricinus communis16. Ricin has
been known as a poison for years, usually through
livestock deaths. One to three seeds may be fatal
to a child; two to four may be poisonous to an
adult, while eight may be fatal. A fatal ingested
dose for human is about 1 µg/kg17. Because the
alimentary tract destroys lots of ricin, it is much
more potent when administered paraenterally.
The toxically active A-chain of ricin is a 267
amino acid globular protein and is classed as an N-
glycosidase. The A-chain is protein containing 8 α-helices
and 8 β-sheets18. The B-chain is composed of 262
amino acid residues and is classed as a lectin. The
B-chain has an affinity for binding to galactosides16
and posseses two galactose binding sites that are
attracted to galactose containing glycoproteins at
the cell surface. The A- and B-chain glycoproteins
are linked by a disulphide bond located at residue
259 of the A-chain and residue 4 of the B-chain19.
Ricin is a glycoprotein with carbohydrate side
chains in the form of mannose-rich N-linked
oligosaccharides and particularly binds to mannose
receptors of cells of the reticuloendothelial system.
The specific sites with potential for binding of high
mannose carbohydrate chains of ricin are at asparagines
10 and 236 of the A-chain, and asparagines 95 and
135 of the B-chain16.
The toxic effects of ricin are essentially the
result of the action of the A-chain, which inactivates
the ribosomes of the cell. It is thought that the
B-chain serves to bind to galactose-containing and/
or mannose-containing structures at the cell surface,
thus allowing the A-chain to enter the cell20. By
this way, the protein is internalised, meaning that
it is taken into the cell as a toxin-binding site
complex in vesicles. The B-chain of ricin facilitates
the escape of the A-chain by binding to the endosomal
membrane allowing the A-chain to pass through
the membrane. Then, the B-chain dissociates from
the A-chain by breaking the disulphide bond. The
A-chain is thus delivered to the cytoplasm where
it is taken up by the golgi apparatus and transported
to the endoplasmic reticulum20.
At the endoplasmatic reticulum, ricin inactivates
the cell ribosomes by elimination of adenine in
specific RNA sequences on the 28S ribosomal
subunit21. A single A-chain molecule is capable of
deactivating every ribosome in the cell thus halting
protein synthesis and culminating in cell death. It
is important to note that the toxin is specific for
eukaryotic ribosomes. A hairpin loop on the 28S
rRNA containing the tetranucleotide loop GAGA
is the most likely target for attack by ricin on the
ribosome, however it is thought that the ribosome
conformation is an important factor in recognition
by the protein21. Therefore, ricin is not a nucleotide
sequence-specific protein.
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In biological warfare it is expected that ricin
would be released as a toxic cloud. It could also
be injected into specific persons as a terrorist or
sabotage weapon. Additionally, ricin is easy to produce
and is stable. The toxic effects of ricin occur
because it kills the cells of the body that it contacts
when it is taken into the body. Upon inhaling an
adequate amount of ricin, death of persons affected
would be expected in 36-48 h because of difficulty
in breathing and circulatory system also gets effected.
Ingested ricin is expected to cause internal bleeding,
death of vital organs, and death of the individual.
Injected ricin causes death by major organ failure.
The prediction of symptoms to be expected is
based on animal studies and accidental human
exposures, which were not fatal. Symptoms would
probably vary depending on whether ricin was inhaled,
ingested or injected. About three hours after inhaling
ricin, the symptoms expected are cough, tightness
of the chest, breathing difficulty, nausea, and muscle
aches. This would progress to a severe inflammation
of the lungs and airways, increased breathing difficulty,
cyanosis, and death in 36-48 h from failure of the
breathing and circulatory systems. Ingestion of ricin
would be expected to cause nausea and vomiting,
internal bleeding of the stomach and intestines,
failure of the liver, spleen, and kidneys, and death
of the individual by collapse of the circulatory vessels.
No specific affects on the lungs and airways would
be expected. If injected, ricin causes marked death
of muscles and lymph nodes near the site of injection
and probable failure of major organs and death of
the individual22.
3.1.2 Abrin
Abrin is a potent toxin that has been isolated
from the seeds of Abrus precatorius (or Rosary
pea). Its use as a tool for research was described
in 1972 by Sharon and Lis23. Abrin exists in two
forms, abrin a and abrin b. Both are composed of
two chains, A-chain and B-chain. A disulphide bond
between Cys247 of the A-chain and Cys8 of the
B-chain links the A- and B-chains. The A-chain is
251 residues and is divided into 3 folding domains.
The A-chain catalytically inactivates 60S ribosomal
subunits by removing adenine from positions 4 and
324 of 28S rRNA, therefore inhibiting protein synthesis.
The B-chain is a galactose specific lectin that
facilitates the binding of abrin to cell membranes24,25.
The B-chain of both forms of abrin consists of 268
amino acid residues and shares 256 identical residues.
Comparison of their sequences with that of the
ricin's B-chain shows that 60 per cent of the residues
of abrin's B-chain are identical to those of the
ricin's B-chain and that two saccharide-binding
sites in ricin B-chain identified by a crystallographic
study are highly conserved in abrin B-chain26.
The mechanism of toxic action of abrin is identical
to that of ricin16 but the toxicity of abrin in mice
is 75 times higher than that of ricin (0.04 µg/kg for
abrin compared to 3 µg/kg for ricin). The diagnosis,
clinical features, treatment, protection, prophylaxis
and so on is the same as was described above for
ricin intoxications27. Recently, similar a highly toxic
RIP protein from seeds of the Abrus pullchelus,
entitled pulchellin, was isolated and characterised28.
3.1.3 Viscumin
Viscumin (Mistletoe lectin I, ML I), inevitable
to the family of Ribosome-inactivating proteins (RIP),
was identified in the late 1980s as the main
pharmacologically-active ingredient of mistletoe
(Viscum album) extract and is largely responsible
for its toxicity29. It is comparable in toxicity to ricin
and acts by the same mechanism. When viscumin
binds to its target cell, protein synthesis in that cell
is interrupted as a result of the A-chain's enzymatic
activity, like a ricin. This interruption induces a
cellular stress response, which triggers the release
of cytokines by the target cell and, at high viscumin
concentrations, apoptosis of the cell occurs. The
association of A- and B-subunits is predominantly
hydrophobic in nature30. Viscumin has a concentration-
dependent activity profile unique to plant toxins. It
starts with lectin-dependent mitogenicity and then
covers toxicity and cell agglutination, associated
with shifts in the monomer/dimer equilibrium. Each
lectin subunit harbors two sections for ligand contact31.
3.1.4 Volkensin
Volkensin is a lectin from Adena volkensii
(the kilyambiti plant) that is comparable in toxicity
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to ricin and that acts by the same mechanism (a
ribosome-inactivating protein)32. The plant is a relatively
unattractive and toxic succulent plant found in
Africa that appears to be of little interest. However,
it has proven to be useful as a research reagent
in neurology because of its ability to be taken up
and transported by certain types of nerves. There
may be pressure to develop commercial sources
for the research community22. Volkensin is probably
the most potent plant toxin known, with an LD50
for rats of 50-60 ng/kg33.
3.1.5 Modeccin
Modeccin is a lectin from the roots of Adenia
digitata an African succulent plant that is comparable
in toxicity to ricin34 and acts by the same mechanism35,27.
The plant does not seem to have any significant
uses, such as a food or as medicine, and so is not
available in quantities comparable to abrin, let alone
ricin. However, the seed does seem to be readily
available. The subunits of modeccin were isolated
(subsequently referred to as modeccin 4B), purified
from the roots of Adenia digitata by affinity
chromatography on Sepharose 4B36. There is A-
subunit (Mol Wt 26 000), which inhibits protein
synthesis, and  B-subunit (Mol Wt 31 000), which
binds to cells. A second form of modeccin, not
retained by Sepharose 4B, was purified by affinity
chromatography on acid-treated Sepharose 6B: this
form is subsequently termed modeccin 6B. Modeccin
6B has a molecular weight indistinguishable from
that of modeccin 4B, and consists of two subunits
of Mol Wts 27 000 and 31 000, joined by a disulphide
bond. The subunits were not isolated because of
their high insolubility in the absence of sodium
dodecyl sulphate. As compared with modeccin 4B,
modeccin 6B is slightly less toxic to animals, does
not agglutinate erythrocytes, and is a more potent
inhibitor of protein synthesis in a lysate of rabbit
reticulocytes, giving 50 per cent inhibition at a
concentration of 0.31 mg/ml37.
3.2 ANIMAL TOXINS
There are numerous protein toxins produced
by many different animal sources, such as snakes,
scorpions, spiders, insects, frogs, sea anemones,
etc. Only conotoxins, the toxic principle of marine
snails of the genus Conus, are presented on the
control list of the Australian Group.
3.2.1 Conus Toxins (Conotoxins)
These are toxic peptides produced by the fish-
hunting marine snails of the genus Conus. The
conotoxins (a mixture of toxic substances produced
by snails) are used to paralyse the fish being attacked38.
For centuries, members of the Conidae family have
been collected for their unique and intricately designed
shells. Only during the last few decades have cone
shells become an exciting area for scientific research.
Cone shells are marine snails and are found in reef
environments throughout the world. They prey upon
other marine organisms, immobilising them with
unique venoms. They can be dangerous for human
beings, too. There have been 30 recorded cases
of human envenomation by fish-eating cone shells,
in some cases fatal39.
The composition of the venom differs greatly
between species and between individual snails within
each species, each optimally evolved to paralyse
its prey. The active components of the venom are
small peptides toxins, typically 12-30 amino acid
residues in length. They have  very tight conformations
by multiple disulphide bridges. These patterns of
disulphide bridge help to define a number of structural
classes of conotoxin. Today several tens of conotoxins
are known and these are divided into four groups.
α-conotoxins are the shortest and have only two
disulphide bridges. µ-conotoxins, ω-conotoxins,
∆-conotoxins, and κ-conotoxins contain three disulphide
bridges between different cysteine residues of peptide
chain40.
The paralytic components of the venom, that
have been the focus of recent investigation, are
the α-, ω-, and µ-conotoxins. All of these conotoxins
act by preventing neuronal communication, but each
targets a different aspect of the process to achieve
this. The α-conotoxins target nicotinic ligand-gated
channels, the µ-conotoxins target the voltage-gated
sodium channels and the omega conotoxins target
the voltage-gated calcium channels. 
Another class of peptides from Conus venoms
are the conantokins, the first peptide antagonists
which target to the major excitatory receptors in
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the vertebrate central nervous system, glutamate
receptors. The conantokins selectively inhibit a subtype
of glutamate receptor, the N-methyl-D-aspartate
(NMDA) receptor, which are ligand-gated Ca channels.
The conantokins cause rather striking and till this
time, little explored biological effects41.
Individual conotoxins, even within the same
class, can vary greatly in lethality towards mammals.
Some of the tremor-inducing ω conotoxins are not
lethal, whereas others of the same group are lethal
at low levels. However, they are only toxic in rats
and mice when administered intracranially (into
the brain). Some α conotoxins have lethal doses
as low as 25 µg/kg for mouse. This may be an
overestimate of toxicity because it is determined
from the dose required to kill a mouse in 20 min.
In addition, it has to be borne in mind that the
toxicity of the complex mixture of peptides that is
cone snail venom, may be much greater than the
sum of its parts because of the synergistic interaction
between toxins acting on different aspects of neural
function. Incidents of cone snails killing people are
known to have occurred.
3.3 MICROBIAL TOXINS
Protein toxins represent numerous groups of
toxic compounds, produced by different pathogenic
bacteria. These bacterial toxins are: botulinum toxins,
Clostridium perfringens toxins, Corynebacterium
diphteriae toxin, Staphylococcus aureus toxins,
shigatoxin, verotoxin, cholera toxin, and tetanus toxin.
3.3.1 Botulinum Toxins
Botulinum toxin is very strong poison derived
from the genus of anaerobic bacteria named Clostridia.
Seven antigenic types of botulinum toxin exist42,
designated from A through G. They can be identified
based on antibody cross-reactivity studies. Clostridium
botulinum is a familiar bacterium that causes botulism,
a form of food poisoning43. Naturally occurring
botulism is the disease that results from the absorption
of botulinum toxin into the circulation from a mucosal
surface (gut, lung) or through a wound. It does not
penetrate the intact skin. The toxin irreversibly
binds to peripheral cholinergic synapses, preventing
the release of the neurotransmitter acetylcholine
from the terminal end of motor neurons. This leads
to muscle paralysis, and in severe cases, can lead
to a need for mechanical respiration44. Patients
with botulism typically present with difficulty in
speaking, seeing and/or swallowing. Prominent
neurologic findings in all forms of botulism include
ptosis, diplopia, blurred vision, dysarthria and dysphagia.
Patients typically are afebrile and do not have an
altered level of consciousness. Patients may initially
suffer from gastrointestinal distress, nausea, and
vomiting, preceding neurological symptoms45.
3.3.2 Clostridium Perfringens Toxins
The gram-positive pathogen Clostridium
perfringens is a major cause of human and veterinary
enteric disease largely because this bacterium can
produce several toxins when present inside the
gastrointestinal tract. Clostridium  perfringens
food poisoning is one of the more common problem
in the industrialised world46. The enteric toxins of
Clostridium perfringens share two common features:
(i) they are all single polypeptides of modest (~25-
35 kDa) size, although lacking in sequence homology,
and (ii) they generally act by forming pores or
channels in plasma membranes of the host cells.
These enteric toxins include Clostridium perfringens
enterotoxin (CPE), which is responsible for the
symptoms of a common human food poisoning and
acts by forming pores after interacting with intestinal
tight junction proteins. Two other Clostridium
perfringens enteric toxins, ε-toxin (a bioterrorism
select agent) and β-toxin, cause veterinary
enterotoxemias when absorbed by the intestine.
Clostridium perfringens enterotoxin (β-toxin) has
been shown to be the virulence factor responsible
for causing the symptoms of Clostridium perfringens
food poisoning. β-toxin is a single polypeptide chain
with a molecular weight of 3.5 kDa that binds to
receptors on the target epithelial cells. Through a
unique four-step membrane action it finally causes
a breakdown in normal plasma membrane permeability
properties47. Also β- and ε-toxins apparently act
by forming oligomeric pores in intestinal or extra-
intestinal target tissues. Other Clostridium perfringens
toxins have different effect. Clostridium perfringens
α-toxin is able to lyse erythrocytes via calcium
channels activation48. The main biological activity
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of epsilon-toxin is the production of oedema in
various organs49 and cytoskeletal changes and plasma
membrane functional alteration50.
3.3.3 Corynebacterium Diphteriae Toxin
Diphtheria toxin is an extracellular protein of
Corynebacterium diphtheriae that inhibits protein
synthesis and kills susceptible cells51. Corynebacterium
diphtheriae is responsible for diphtheria. Diphtheria
is a contagious, airborne, toxin-producing infection.
It is considred as potential tools in bioterrorism52.
It is characterised by the formation of a gray
resistant pseudo-membrane in the lining of the
mucous membrane of the upper respiratory tract
as well as in the tonsils. Certain forms of the
disease may be fatal. The global mortality rate for
diphtheria is 5 per cent to 10 per cent and may
reach 20 per cent among children under 5 and
adults over 40. In 1888, Roux discovered the diphtheria
toxin secreted by Corynebacterium diphtheriae.
In 1890, the work of von Behring and Kitasato on
antibodies to diphtheria antitoxins made it possible
to envision their use in treating the disease53. In
1897, Ehrlich established a standardised diphtheria
toxin. These passive serum therapies would soon
lead to active immunization. Diphtheria vaccines
were first used in France in the 1920s. Mass
immunization only began in the 1950s. The diphtheria
vaccines used today throughout the world against
the pathogenic and lethal effects of the diphtheria
toxin are obtained by detoxification of the toxoid
with formalin.
3.3.4 Staphylococcus Toxins
Staphylococcus aureus is a spherical bacterium
(coccus) which on microscopic examination appears
in pairs, short chains, or bunched, grape-like clusters.
These organisms are gram-positive. Some strains
are capable of producing a highly heat-stable protein
enterotoxins, which range in size from 19 kDa to
26 kDa, that cause illness in human beings. Seven
immunologically different forms of Staphylococcus
enterotoxins is known: A, B, C1, C2, C3, D and
E. These toxins are responsible for symptoms of
food poisoning that follow consumption of food
contamined by Staphylococcus bacteria.
The onset of symptoms in staphylococcal food
poisoning is usually rapid, and in many cases acute,
depending on individuals susceptibility to the toxin,
the amount of contaminated food eaten, the amount
of toxin in the food ingested, and the general health
of the victim. The most common symptoms are
nausea, vomiting, retching, abdominal cramping,
and prostration. Some individuals may not always
demonstrate all the symptoms associated with the
illness. In severe cases, headache, muscle cramping,
and transient changes in blood pressure and pulse
rate may occur. Recovery generally takes two
days, however, it is not unusual for complete recovery
to take three days and sometimes longer in severe
cases. Infective dose - a toxin dose of < 1.0 µg
in contaminated food will produce symptoms of
Staphylococcal intoxication. This toxin level is
reached when Staphylococcus aureus populations
exceed 100,000/g.
Staphylococcus aureus also produces
hemolytically-active toxins, so called hemolysins.
Three hemolysins, α-toxin, β-toxin, and ∆-toxin,
are known and each of them exist in more
molecular forms. Their mechanism of toxic action
is different54.
α-toxin, also known as α-hemolysin, is one of
the many virulence factors produced by
Staphylococcus aureus55. α-toxin is a single polypeptide
chain known in four molecular forms with a molecular
weight from 26 kDa to 39 kDa. The majority of
Staphylococcus aureus strains isolated from human
beings produce this toxin. α-toxin has been found
to be lethal in animals, causing respiratory paralysis,
vascular and smooth muscle spasms, and tissue
necrosis56.
β-toxin (β-hemolysin) is one of the several
extracellular proteins produced by Staphylococcus
aureus. It is a sphingomyelinase which disrupts
the membranes of erythrocytes and other mammalian
cells. Despite its characterised mechanism of action,
the role of β-toxin in causing diseases in human
beings and animals remains unclear57.
∆-toxin (∆-hemolysin) is heat-stable peptide,
having molecular weight 5 kDa, composed of 26
amino acid residues. Its molecules create amphiphatic
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helix with hydrophilic amino acid residues on one
side of long axis of molecule, hydrophobic residues
on the other side and produced lesions in biological
membranes very similar to those produced by Melittin
and Triton X-10055.
Staphylococcus toxins are suitable for use in
warfare and terrorism in aerosolised form7.
3.3.5 Shiga Toxin
Shigella are the most important organisms that
can cause dysentery. Shigella dysenteriae type 1
(Sd1) is the most virulent of the four serogroups
of Shigella58. The Sd1 is the only cause of epidemic
dysentery. In addition to bloody diarrhoea, the illness
caused by Sd1 often includes abdominal cramps,
fever, and rectal pain. Less frequent complications
of infection with Sd1 include sepsis, seizures, renal
failure, and the haemolytic uraemic syndrome (HUS)59.
Altered arachidonic acid metabolism has been
implicated in the pathogenesis of renal injury in the
HUS caused by shigatoxin60. Approximately 5-15
per cent of Sd1 cases are fatal. Shiga toxin works
as enterotoxin, neurotoxin, and cytotoxin. It consists
of two protein subunits. Subunit-A performs as
N-glycosidase which splits adenin on ribosomes
and inhibits protein synthesis61.
3.3.6 Verotoxin
The verotoxin, or shiga-like toxin family is a
group of closely related toxins produced by certain
pathogenic strains of Escherichia coli. Verotoxin-
producing Escherichia coli, especially of serotype
O157:H7, cause a zoonotic food or waterborne
enteric illness that is often associated with large
epidemic outbreaks as well as the HUS, the leading
cause of acute renal failure in children62. These
strains are a significant cause of human hemorrhagic
colitis. In addition, they are both waterborne and
foodborne and may also be transmitted from person-
to-person by the oral-fecal route. In adults, illness
caused by verotoxin may last several days. In children
and the elderly, the illness can be fatal63. Structure
and mechanism of toxic action of verotoxin is equal
to shigatoxin but recently new pieces of knowledge
were obtained64. It has been known, that following
the intracellular routing of shigatoxin and/or verotoxin
to the endoplasmic reticulum and nuclear membrane,
the toxins translocate into the cytoplasm and target
ribosomes for the damage. However, numerous
recent studies have shown that these toxins trigger
programmed cell death, signaling cascades in intoxicated
cells. The mechanisms of apoptosis induction by
these toxins are emerging, and the data published
to date suggest that the toxins may signal apoptosis
in different cells types via different mechanisms65.
3.3.7 Cholera Toxin
Vibrio cholerae is a gram-negative, curved
rod bacteria. Vibrio cholerae is responsible for
approximately seven pandemic infections of extreme
diarrhea and dehydration across the globe, resulting
in millions of death throughout the centuries. Vibrio
cholerae as pathogen has been co-existing with
mankind long before we were ever capable of
detecting it, or understanding its mechanism of
infection. Until recently, the methods to confront
this pathogen, and begin to understand its function
were not available.
The biochemistry of cholera toxin has been
well characterised over the recent years66,67 Cholera
toxin is a heterohexameric protein, composed of
five subunits B and one subunit A (AB5, choleragen),
responsible for the symptoms produced by Vibrio
cholerae infection. In the first step of cell intoxication,
the B-pentamer of the toxin binds specifically to
the branched pentasaccharide moiety of ganglioside
GM1 on the surface of target human intestinal
epithelial cells.
The normal function of GM1 is not clearly
understood but it has been implicated in numerous
signal-transduction pathways. Cholera toxin and
GM1 complex show no major conformational change,
but it is theorised about that the A subunit of the
cholera toxin is inserted into the cell. This translocation
takes approximately 15 minutes and during this
time it is theorised that the A subunit is cleaved
along a disulphide bridge between A1 and A2, which
keeps the protein inactive68.
The A1-subunit of cholera toxin is the enzymatically
active portion of the protein molecule, and it acts as
an ADP-ribosyltransferase. It catalyses a transfer of
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an ADP-ribose from an NAD+ to the arginine at
location 187 in the α-chain of the regulatory protein69
Gs. This ribosylation of Gs stabilises the GTP
bound form of the protein, lower its GTPase activity
creating a near-constitutively on signal for the
generation of adenylyl cyclase, and therefore elevating
cAMP levels. This high cAMP level results in the
activation of the sodium pumps in the lumen of
the cell through a cAMP-dependent kinase pathway,
forcing out Na+ ions. This resultant electrochemical
imbalance drives out Cl- and H2O to balance the
Na+ release. The net flow of fluid is now out of
balance and the cells attempt to compensate for
the dehydration through removal of fluid from the
blood. This is the biochemical process responsible
for the clinical characteristics of epidemic cholera
infection70. Europe and America were largely clear
of cholera cases.
3.3.8 Tetanus Toxin
The illness known as tetanus is caused by a
neurotoxin produced by the anaerobic bacterium
Clostridium tetani. It acts upon the presynaptic
membranes of both central and peripheral nervous
systems to block the release of neurotransmitters.
Tetanus toxin is synthesised as a single polypeptide
chain of 150 kDa, and undergoes proteolytic cleavage
to produce a di-chain toxin consisting of the N-
terminal 50 kDa fragment (light chain) linked by
a disulphide bond to the 100 kDa carboxy terminal
fragment (heavy chain). Fragment C (the C-terminal
half of the heavy chain) retains ganglioside binding
activity which is essential for the binding of the
toxin to neuronal cells71,72. Tetanus toxin is likewise
botulinum toxin a neurotoxin and their  molecular
structures and mechanism of action are very similar73.
The LD50 in unvaccinated human beings is estimated74
at < 2.5 ng/kg. It is a powerful neurotoxin which
may be fatal if inhaled or introduced through a
wound. It causes muscle rigidity or spasms, paralysis,
and death. If contact to this toxin occurs, flush
eyes, skin or wounds thoroughly with water. Seek
medical attention, since supportive therapy will be
required if symptoms occur. Immune globulin may
also be a part of the medical treatment.
4 . CONCLUSIONS
Natural protein toxins represent a family of
extremely potent toxic compounds, some of which,
such as botulinum toxin, is the most potent toxin
known till date. The use of toxins for terrorist
affects aims in the form of aerosols is a perfectly
credible eventuality. A number of toxins could be
used in a terrorist attack, including ricin and botulinum
toxins. Progress in molecular biology caused that
it is easy to produce and can lead to massive
destruction. It will be possible produce whatever
toxin in a short time. Preparedness among physicians,
first responders, and public health officials is especially
important because these agents are very dangerous.
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